VF-001

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameVF-001
Drug Alias NameVF001-DP LDVF001-DP HDVitroGroVF-001VF-001-DP-HD +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTissue replacementsInsulin-like growth factor I receptor agonists
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsUlcerPathologic ProcessesLeg Ulcer +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFactor Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFactor Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsUlcerPathologic ProcessesLeg Ulcer +[8] 

Other Information

ATC CodeN/A
Related LinksN/A